Dr John Albert Parent, DPM in Sandown, NH - Podiatrist

Dr John Albert Parent, DPM is a Podiatrist based in Sandown, New Hampshire. Dr John Albert Parent is licensed to practice in New Hampshire (license number 0167) and his current practice location is 5 Valerie Court, Sandown, New Hampshire. He can be reached at his office (for appointments etc.) via phone at (603) 887-0597.

NPI number for Dr John Albert Parent is 1720060312 and his current mailing address is 5 Valerie Court, Sandown, New Hampshire. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1720060312.

Contact Information

	Dr John Albert Parent, DPM
	5 Valerie Court, Sandown, NH 03873
	(603) 887-0597
	Not Available

Healthcare Provider's Profile

Full Name	Dr John Albert Parent
Gender	Male
Speciality	Podiatrist
Location	5 Valerie Court, Sandown, New Hampshire
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1720060312
Provider Enumeration Date: 11/18/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr John Albert Parent such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1720060312	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
213E00000X	Podiatrist	0167 (New Hampshire)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John Albert Parent is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John Albert Parent, DPM 5 Valerie Court, Sandown, NH 03873 Ph: (603) 887-0597	Dr John Albert Parent, DPM 5 Valerie Court, Sandown, NH 03873 Ph: (603) 887-0597

News Archive

Researchers discover molecular mechanism responsible for low back pain

Italian researchers at the Catholic University of Sacred Heart in Rome found an important molecular mechanism responsible for low back pain and other acute vertebral problems like cervical axial pain, all due to aging and degeneration of the vertebral column.

Neurobiologists uncover reason for defects in the blood-brain barrier of Huntington's disease patients

By using induced pluripotent stem cells to create endothelial cells that line blood vessels in the brain for the first time for a neurodegenerative disease, University of California, Irvine neurobiologists and colleagues have learned why Huntington's disease patients have defects in the blood-brain barrier that contribute to the symptoms of this fatal disorder.

Essen Instruments, Origene Technologies partner to co-develop ion channel cell lines

Essen Instruments Inc. and OriGene Technologies, Inc. today announced a strategic alliance to co-develop ion channel cell lines. Essen, based in Ann Arbor Michigan, is a leading provider of life science products and services, including ion channel discovery and safety assays. OriGene, headquartered in Rockville, Maryland, specializes in the creation and supply of gene-centric products, and has a collection of over 30,000 human full length cDNA clones.

Reading labels on food products can prevent obesity

An international team of scientists headed from the University of Santiago de Compostela ensures that reading the labels on food products is linked to obesity prevention, especially in women. According to the study which used data from the USA, female consumers who consult food labels weigh nearly 4 kilograms less.

New blood tests may detect pancreatic cancer more effectively

A new diagnostic tool developed by Van Andel Research Institute (VARI) scientists has shown promising results when used with patients of pancreatic cancer, one of the deadliest forms of cancer due to the difficulty of diagnosing it in its early stages. The method, which studies carbohydrate structures in the bloodstream, could lead to the development of blood tests that can detect cancer more effectively.

Dr John Albert Parent, DPM - Podiatrist in Sandown, NH